Stephanie LaVergne

I work clinically as an infectious diseases consultant. I am also a researcher at Colorado State University, investigating immune and coagulation profile differences in patients infected with SARS-CoV-2 who had various COVID-19 presentations. My research background has been in investigating the immunopathology and T cell responses to Lassa and Ebola viruses at Scripps Research. I have a special interest in the pathophysiology of post viral syndromes. I studied immunologic markers and virus-specific T cell activation in those with post Ebola syndrome and Lassa virus sequelae, and I have continued this line of focus at CSU.